PROCEPT BioRobotics (PRCT) Receivables - Net (2020 - 2026)
PROCEPT BioRobotics has reported Receivables - Net over the past 7 years, most recently at $96.4 million for Q1 2026.
- Quarterly Receivables - Net rose 21.6% to $96.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $96.4 million through Mar 2026, up 21.6% year-over-year, with the annual reading at $83.5 million for FY2025, 0.04% changed from the prior year.
- Receivables - Net was $96.4 million for Q1 2026 at PROCEPT BioRobotics, up from $83.5 million in the prior quarter.
- Over five years, Receivables - Net peaked at $96.4 million in Q1 2026 and troughed at $7.0 million in Q1 2022.
- The 5-year median for Receivables - Net is $56.1 million (2024), against an average of $51.5 million.
- Year-over-year, Receivables - Net surged 242.11% in 2022 and then increased 0.04% in 2025.
- A 5-year view of Receivables - Net shows it stood at $15.3 million in 2022, then skyrocketed by 216.76% to $48.4 million in 2023, then soared by 72.6% to $83.5 million in 2024, then rose by 0.04% to $83.5 million in 2025, then grew by 15.39% to $96.4 million in 2026.
- Per Business Quant, the three most recent readings for PRCT's Receivables - Net are $96.4 million (Q1 2026), $83.5 million (Q4 2025), and $84.5 million (Q3 2025).